MICHELLE MACDONALD: Open Payments
NPI 1194819003 · SUTTONS BAY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 37 payments from 12 companies in 2025. Trend: 2023 $1,814 · 2024 $817 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $356 |
| AstraZeneca Pharmaceuticals LP | 8 | $137 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| PFIZER INC. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Exact Sciences Corporation | 1 | $27 |
| Astellas Pharma US Inc | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
Products named: QULIPTA, UBRELVY, FARXIGA, REXULTI, VRAYLAR, CAPLYTA, NEXIUM, The Cologuard Plus Collection Kit.
Industry payments across MI — which companies pay providers there.
